Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Number of holders
-
17
-
Total 13F principal, excl. options
-
229,755,000
-
Principal change
-
+229,755,000
-
Total reported value, excl. options
-
$289,039,000
-
Value change
-
+$289,039,000
-
Number of buys
-
17
-
Price
-
$1.26
Significant Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q3 2021
17 filings reported holding 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 as of Q3 2021.
CARDLYTICS INC - NOTE 1.000% 9/1 has 17 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $229,755,000 of principal
.
Largest 10 bondholders include CITADEL ADVISORS LLC ($66,500,000 of principal), Linden Advisors LP ($65,612,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($40,778,000 of principal), LAZARD ASSET MANAGEMENT LLC ($16,000,000 of principal), DeepCurrents Investment Group LLC ($10,725,000 of principal), GUARDIAN POINT CAPITAL, LP ($5,000,000 of principal), GABELLI FUNDS LLC ($4,770,000 of principal), Nicholas Investment Partners, LP ($4,585,000 of principal), JPMORGAN CHASE & CO ($3,500,000 of principal), and Verition Fund Management LLC ($3,119,000 of principal).
This table shows the top 17 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.